Jul 26, 2024 8:35am EDT ProMIS Neurosciences Reports Positive Top-Line Data from its Phase 1a Alzheimer's Trial
Jul 26, 2024 8:30am EDT ProMIS Neurosciences Announces Up to $122.7 Million Private Placement Financing